全球生物技术市场规模、份额、趋势和成长分析报告（2026-2034）

预计生物技术市场将从 2025 年的 2.64 兆美元成长到 2034 年的 8.79 兆美元，2026 年至 2034 年的复合年增长率为 14.3%。

随着生物技术的应用不断变革医疗保健、农业和工业流程，全球生物技术市场正在快速扩张。生物技术是利用生物系统和生物体开发疫苗、生物製药、基因改造作物和诊断工具等产品的技术。生命科学研发投入的不断增加以及对创新医疗手段日益增长的需求是推动市场成长的主要因素。

基因编辑、合成生物学和生物资讯学等技术的进步正显着加速新型生物技术解决方案的开发。製药公司和研究机构正越来越多地利用生物技术开发标靶治疗和个人化医疗。政府资助以及学术机构与生技公司之间的合作也正在推动这项产业的发展。

随着对先进治疗方法和永续生物产品的需求不断增长，生物技术市场预计将进一步扩大。在医疗保健、农业和环境管理等领域的应用不断拓展，将持续创造新的机会。持续的研究和创新将在塑造生物技术产业的未来方面发挥至关重要的作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球生技市场：依技术划分

• 市场分析、洞察与预测
• 奈米生物技术
• 组织工程与再生医学
• DNA定序
• 基于细胞的检测
• 发酵
• PCR技术
• 层析法
• 其他的

第五章 全球生技市场：依应用划分

• 市场分析、洞察与预测
• 卫生保健
• 食品和农业
• 自然资源/环境
• 工业流程
• 生物资讯学
• 其他的

第六章 全球生技市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • AstraZeneca
  • Gilead Sciences Inc
  • Bristol-Myers Squibb
  • Sanofi
  • Biogen
  • Abbott Laboratories
  • Pfizer Inc
  • Amgen Inc
  • Novo Nordisk A/S
  • Merck KGaA
  • Johnson & Johnson Services Inc

The Biotechnology Market size is expected to reach USD 8.79 Trillion in 2034 from USD 2.64 Trillion (2025) growing at a CAGR of 14.3% during 2026-2034.

The global biotechnology market is experiencing rapid expansion as biotechnology applications continue to transform healthcare, agriculture, and industrial processes. Biotechnology involves the use of biological systems and organisms to develop products such as vaccines, biologic drugs, genetically engineered crops, and diagnostic tools. Increasing investments in life sciences research and the growing demand for innovative medical treatments are major factors driving market growth.

Advancements in technologies such as gene editing, synthetic biology, and bioinformatics are significantly accelerating the development of new biotechnology solutions. Pharmaceutical companies and research institutions are increasingly utilizing biotechnology to develop targeted therapies and personalized medicines. Government funding and collaborations between academic institutions and biotech companies are also strengthening the industry.

Looking ahead, the biotechnology market is expected to grow further as demand for advanced therapies and sustainable bioproducts increases. Expanding applications in healthcare, agriculture, and environmental management will continue to create new opportunities. Continuous research and technological innovation will play a key role in shaping the future of the biotechnology industry.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Nanobiotechnology
• Tissue Engineering and Regeneration
• DNA Sequencing
• Cell-based Assays
• Fermentation
• PCR Technology
• Chromatography
• Others

By Application

• Health
• Food & Agriculture
• Natural Resources & Environment
• Industrial Processing
• Bioinformatics
• Others

COMPANIES PROFILED

• AstraZeneca, Gilead Sciences Inc, BristolMyers Squibb, Sanofi, Biogen, Abbott Laboratories, Pfizer Inc, Amgen Inc, Novo Nordisk AS, Merck KGaA, Johnson Johnson Services Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOTECHNOLOGY MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Nanobiotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Tissue Engineering and Regeneration Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. DNA Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Cell-based Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Fermentation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. PCR Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOTECHNOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Health Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Food & Agriculture Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Natural Resources & Environment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Industrial Processing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Bioinformatics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOTECHNOLOGY MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Technology
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Technology
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Technology
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Technology
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Technology
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL BIOTECHNOLOGY INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 AstraZeneca
  • 8.2.2 Gilead Sciences Inc
  • 8.2.3 Bristol-Myers Squibb
  • 8.2.4 Sanofi
  • 8.2.5 Biogen
  • 8.2.6 Abbott Laboratories
  • 8.2.7 Pfizer Inc
  • 8.2.8 Amgen Inc
  • 8.2.9 Novo Nordisk A/S
  • 8.2.10 Merck KGaA
  • 8.2.11 Johnson & Johnson Services Inc